logo
Israeli Soldiers Killed At Least 410 People at Food Aid Sites in Gaza This Month

Israeli Soldiers Killed At Least 410 People at Food Aid Sites in Gaza This Month

The Intercept2 days ago

Support Us
© THE INTERCEPT
ALL RIGHTS RESERVED
A man carries a flour sack from the World Health Organization warehouse, in Gaza City, Gaza, on June 26, 2025. Photo: Saeed M. M. T. Jaras/Anadolu/Getty Images
The Israeli military has killed at least 410 people trying to get food at Israeli-run aid sites in Gaza in the past month.
This constitutes 'a likely war crime' that violates international standards on aid distribution, according to the United Nations. 'Desperate, hungry people in Gaza continue to face the inhumane choice of either starving to death or risk being killed while trying to get food,' the U.N. human rights office said. Palestinian health authorities reported that Israel killed 44 people waiting for aid in separate incidents in southern and central Gaza just on Tuesday this week. Israeli soldiers have reportedly killed aid-seekers with bullets, tank shells, and drone-mounted weapons.
Israeli officers and soldiers said that they were ordered to deliberately fire at unarmed civilians waiting for humanitarian aid in an investigation published by the Israeli newspaper Haaretz on Friday; the military prosecution has called for a review into possible war crimes, according to Haaretz.
The Israeli military has said reports about casualties at aid sites have prompted 'thorough examinations…in the Southern command' and that 'instructions were issued to forces in the field following lessons learned.' 'The aforementioned incidents are under review by the competent authorities,' an unnamed spokesperson for the Israeli military said in a statement emailed to The Intercept.
The aid distribution sites are run by the Gaza Humanitarian Foundation, a nonprofit formed earlier this year for the purpose of distributing aid in collaboration with the Israeli government and American private military and security companies, under a plan created by the U.S. and Israeli governments.
An open letter published earlier this week by more than a dozen human rights and legal advocacy groups, including the Center for Constitutional Rights and the International Commission of Jurists, condemned the organization. The letter stated that the privatized, militarized aid distribution system — and close collaboration with Israeli authorities — undermines 'the core humanitarian principles of humanity, neutrality, impartiality, and independence.' They urged corporate entities, donors, and individuals to suspend action or support that undermines international humanitarian law and 'to reject any model that outsources life-saving aid to private, politically-affiliated actors and to press for the urgent restoration of independent, rights-based humanitarian access for all civilians in Gaza.'
The Gaza Humanitarian Foundation has been marred with controversy from the start; the former head, Jake Wood, quit in May, worrying that 'it is not possible to implement this plan while also strictly adhering to the humanitarian principles of humanity, neutrality, impartiality, and independence.' Boston Consulting Group, which helped run the business, also backed out. The Israeli military said that they allow 'the American civilian organization (GHF) to distribute aid to Gaza residents independently, and operate in proximity to the new distribution zones to enable the distribution alongside the continuation of IDF operational activities in the Gaza Strip' in a statement to the Intercept. The Gaza Humanitarian Foundation did not respond to a request for comment.
The American government, however, appears to be committed to this way of providing aid. On Tuesday, the Trump administration authorized a $30 million grant for the Gaza Humanitarian Foundation, according to documents viewed by Reuters. Security guards ride aboard trucks carrying humanitarian aid in Beit Lahia, northern Gaza, on June 25, 2025. Photo: Ahmad Salem/Bloomberg/Getty Images
Finding food has become a horrific risk for many in Gaza. Rolla Alaydi, a Palestinian American, provided The Intercept with a voice note from her cousin, Maher Ahmed, detailing how he went to an aid site on June 1 and witnessed a fatal bullet strike his friend.
Maher had gone three days without flour, so when the Gaza Humanitarian Foundation first opened its facilities, he went with three friends, prompted by an invitation from a food bank. At 6 a.m., on June 1, they went to Dewar Al'aalam for food distribution, and the Americans started to signal to them with their hands to enter and take the food, by shouting on a mic 'Take only one box and go home,' Mahar said in the voice note. A group of about 1,000 people went inside. Suddenly, they heard the chaotic sound of gunfire. His friend, Mohammed, was shot in the head, chest, and belly — and killed immediately. They couldn't move for about an hour because of heavy gunfire, so they tried to give Mohammed first aid but failed. The three of them managed to get Mohammed onto a donkey carriage before taking him to Nasser Hospital. 'I survived by a miracle, by a big miracle,' Maher says. 'And I lost my friend, Mohammed. Mohammed was only dreaming of getting a bag of flour for his mother and family.'
Maher wrote in a June 11 Instagram post accompanying a video of Mohammed's funeral that they 'survived the worst together … until a bag of flour took him from me.'
For months, environmental researcher Yaakov Garb has been using satellite data to analyze the design, location, and expansion of these facilities. Garb, a professor at Ben-Gurion University of the Negev, found in an analysis published earlier this month on Harvard Dataverse that most of Gaza's population cannot access these centers in a safe and practical way. Doing so requires crossing the dangerous Netzarim Corridor, entering a buffer zone from which Israel has banned them from entering, or a long walk across a barren rubble field, while carrying a heavy box of food.
Four Israeli-run aid compounds have already been widely reported on by the media, and Garb suspects a fifth is being formed on the coast —given that its construction features appear identical to the other four. All are close to fortified Israeli military positions, he says. 'The fact that four of the five compounds lie south of the Morag corridor — repeatedly indicated by Israeli officials as the intended destination for concentration of Palestinians to be displaced from the remainder of Gaza in an impending intensification of the military attacks — is not reassuring,' Garb notes in his analysis.
Israel's upheaval of Gaza's existing aid distribution system amid warnings of famine has angered Garb. 'To cloak this kind of tactical intervention in humanitarian wrapping rubs me the wrong way,' Garb says. 'If you can't do it properly then get out of the way and let the people who can do it get to work.'
Humanitarian aid experts agree. 'We all saw this coming. To anyone that knows this stuff, it's not a surprise. It is tragic,' says Maryam Z. Deloffre, an associate professor of international affairs at George Washington University who has researched aid distribution systems globally; she explains that this is why multiple nongovernmental organizations and the U.N. said they would not be involved in this way of distributing aid.
Before the war in Gaza broke out, Garb was focused on reviewing satellite imagery to look into waste burning and land contamination in the West Bank and Gaza. But over the last year, he started posting his observations about confusing evacuation warnings, which did not clearly describe which areas populations should flee from, or the so-called humanitarian safe areas, as well as the expansion of these aid compounds. 'They are part and parcel of the same callousness,' he says. 'These evacuation maps — if a student gave me a map like that in an introductory GIS course they would fail — and these are maps where people's lives are hanging in the balance.' Garb has grown increasingly skeptical of the Israeli government's actions. 'I learned to trust less what people are saying and instead trust what I could see from the satellite,' he says.
'I learned to trust less what people are saying and instead trust what I could see from the satellite.'
Garb first started seeing the emergence of these compounds in late April, when he spotted intensive work on some big clearings that seemed different in size and formation to other military installations. He wasn't sure if they would be used to relocate refugees instead. But as Israeli government declarations and media reports started mentioning an alternative aid distribution model in Gaza, he realized that is what these sites were going to be.
Garb's report unpacks how the physical layout of the compounds prioritizes control and surveillance over safety. The aid sites appear to lack key facilities — such as toilets, water, and shade for recipients — and involve crowds moving in narrow lines through fenced aisles. This creates a 'chokepoint': a predictable movement path that allows for no cover or concealment. For the visitor, this kind of design is supposed to induce stress and fear. 'This setup would be particularly distressing for an already traumatized population, especially given the compound's proximity to the Israeli army forces that have been sources of violence they have experienced for almost a year and a half,' Garb writes. Aid sites should ideally have multiple exit points and freedom of movement, as well as facilities, trained deescalation facilitators, and dedicated lanes for vulnerable groups.
Read our complete coverage
Asked to respond to Garb's study and broader criticisms of their conduct around aid sites, an unnamed spokesperson with the Israeli military said it had 'recently worked to reorganize the area through the installation of fences, signage placement, the opening of additional routes, and other measures.' It did not provide further detail on how many routes have opened up, or where the routes are located.
A small detail from Garb's most recent paper has been turned into a meme in recent days. Some readers have interpreted population estimates he included in his report as proof that 377,000 people in Gaza are missing per official Israeli military statistics; Garb clarified to The Intercept that this is a misinterpretation. The numbers in his report refer to estimates for just three particular areas of Gaza, not its entirety; he also noted there was a typo in the map for the al-Mawasi area that he would promptly correct.
The official death toll of Israel's war on Gaza, as reported by the Gaza Health Ministry, stands at more than 55,000. Two reports published in the British medical journal Lancet estimated that the real number is likely closer to 64,000 dead from direct attacks, with the number of deaths from disease, malnutrition, and other health issues related to the conflict potentially climbing above 180,000.
Deloffre, the GWU professor, points out that military involvement in handing out food can be problematic. Two of the key principles of humanitarian work are neutrality (not taking sides in a conflict) and impartiality (providing assistance to everyone without discrimination), Deloffre says. Militaries can't be impartial and neutral when they are party to the conflict, she adds. What's more, 'people are generally afraid of the military; you don't see the military and feel you can approach them.'
Deloffre worries more broadly about backsliding to a time when humanitarian need was not the main driving force behind humanitarian action and decisions about who to help were driven by political interests. She also notes that the core humanitarian principles — mentioned in the open letter — are not legally binding, and are instead adopted by nonstate actors such as NGOs and the Internatinoal Red Cross and Red Crescent Movement. The principles are part of a Red Cross code of conduct, which was codified in the early 90s.
Israel claims that it needs this level of control to ensure aid doesn't get diverted to Hamas. But humanitarian experts say that Israel could have used a good-faith effort to address any such concern through the existing system. Join The Conversation

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Dozens of Palestinians killed in Israeli airstrikes in Gaza
Dozens of Palestinians killed in Israeli airstrikes in Gaza

UPI

time14 hours ago

  • UPI

Dozens of Palestinians killed in Israeli airstrikes in Gaza

Displaced Palestinians wait to receive aid from World Food Program USA on Thursday. Starvation is intensifying amid more Israeli airstrikes against Hamas on the Gaza Strip. Photo by Mohammed Saber/EPA-EFE June 28 (UPI) -- Dozens of Palestinians died in several rounds of Israeli airstrikes from Friday night until Saturday morning, officials said. At least 44 people died in the Gaza Strip since dawn, hospital sources told Al Jazeera Arabic. The Guardian reported at least 62 people died in overnight strikes. The Gaza Health Ministry, which is controlled by the Iran-funded militant group Hamas, said 81 people have died and 422 were wounded over 24 hours. Al Jazeera reported an airstrike in a residential building in Gaza City killed at least 20 Palestinians, including nine children. "We were sitting peacefully when we received a call from a private number telling us to evacuate the entire block immediately -- a residential area belonging to the al-Nakhalah family. As you can see, the whole block is nearly wiped out," Mahmoud al-Nakhala told Al Jazeera. "We still don't know why two, three-story homes were targeted ... It's heartbreaking that people watch what's happening in Gaza -- the suffering, the massacres -- and stay silent. At this point, we can't even comprehend what's happening here anymore," he added. Rescuers were working to remove victims from under rubble. Those hurt were taken to al-Ahli Hospital, which is lacking medical resources. There were also drone strikes elsewhere on Gaza Strip, including in the city of Khan Younis and the Bureij refugee camp. The Guardian reported that a dozen people were killed near a displacement camp near Palestine Stadium in Gaza City, after which a nearby airstrike nearby killed at least 11 people and a family sleeping in a tent was reported to have died in a strike in al-Mawasi, southern Gaza. At least 56,412 Palestinians have been killed 133,054 wounded since the war began on Oct. 7, 2023, according to Gaza's Health Ministry. Hamas' attack on Israel that day killed approximately 1,200 people and 251 hostages were taken. President Donald Trump on Friday said there could be a cease-fire agreement "within the next week" despite no signs of negotiations underway. Humanitarian conditions in Gaza have worsened since Israel resumed airstrikes on March 18 after a cease-fire that ran from Jan. 19 to March 1. Unicef said last week that 60% of water production facilities in Gaza weren't working and acute child malnutrition increased 51% from April to May. In a separate strike in southern Lebanon on Friday, Israel Defense Forces killed Hezbollah terrorist Hassan Muhammad Hammoudi, the military told the Jerusalem Post on Saturday night. Lebanon's President Joseph Aoun accused Israel of continually violating the U.S.-brokered cease-fire deal.

Texas politicians lead effort to study a psychedelic drug. What is ibogaine?
Texas politicians lead effort to study a psychedelic drug. What is ibogaine?

USA Today

time14 hours ago

  • USA Today

Texas politicians lead effort to study a psychedelic drug. What is ibogaine?

Ibogaine is illegal in the U.S., but growing evidence shows its promise treating the effects of traumatic brain injury and substance use disorder. A once obscure traditional psychedelic plant from Africa has made headlines recently as Texas pushes for more research and a prominent Republican wrote a vigorous endorsement of its possible use for the treatment of addiction and for veterans experiencing mental health issues. Ibogaine is illegal for use in the United States, but a growing body of evidence has shown its promise treating the effects of traumatic brain injury and substance use disorder. Earlier in June, Texas Gov. Greg Abbott signed legislation to allocate $50 million for clinical trials approved by the Food and Drug Administration to study ibogaine. Texas is set to lead research into the drug's benefits treating mental health issues and addiction as a potential medication. Former Energy Secretary Rick Perry, also a former Texas governor, wrote a June 27 Washington Post op-ed supporting ibogaine research and criticizing the legacy of the war on drugs, started by President Richard Nixon and touted by President Ronald Reagan. Perry said he has 'come to realize just how wrong that narrative was.' 'That fear-based messaging kept us from exploring treatments that could have saved countless lives,' Perry wrote. Perry and a growing number of conservatives have argued ibogaine could be one of those treatments. Here's what to know about the drug. What is ibogaine? Ibogaine derives from the root of the iboga plant native to western-central Africa. It's been used in ceremonial rituals for centuries. It has hallucinogenic properties. The United States outlawed ibogaine in 1967 along with other psychotropic drugs. The Controlled Substances Act of 1970 placed it as a schedule I hallucinogenic drug, along with marijuana. Ibogaine's classification prevented researchers from studying its effects. But unlike other schedule 1 drugs such as heroin, ibogaine has anti-addictive properties. There are risks since ibogaine can delay the body's normal electrical signals that control heart rhythm, which could lead to death. Other countries, such as Mexico, have allowed its use. American veterans and others have traveled to smaller, clandestine clinics for treatment to deal with depression, post-traumatic stress disorder and addiction. Many clinics are along the border and around cities such as Tijuana. Why is it in the news? At the state and federal level, there is growing interest in studying psychedelic drugs to treat veterans and others. Texas passed legislation earlier in June to study the drug with a public university alongside a company and hospital, Abbott's office said. Dr. Marty Makary, the FDA commissioner, has said expanding research on psychedelic drugs is a top priority for the Trump administration. In his op-ed, Perry cited the experiences of Morgan and Marcus Luttrell, twin combat veterans, who used ibogaine for recovery. Morgan Luttrell is now a Republican congressman from Texas who has advocated for ibogaine and other psychedelic drugs as treatment options. In January 2025, Perry and W. Bryan Hubbard, an advocate for ibogaine treatment, appeared on Joe Rogan's podcast to discuss ibogaine's benefits as a plant-based medicine. Hubbard led a Kentucky task force that sought to use opioid settlement funds to research ibogaine's effects to treat addiction, but the initiative failed to gain support in the state. Hubbard and Perry eventually launched the Texas Ibogaine Initiative, which helped spur the state funding. What has research shown? Research, such as a Stanford University study of 30 male combat veterans, has shown ibogaine's promise. Coupled with magnesium sulfate to address heart effects, ibogaine appeared to reduce symptoms of PTSD, anxiety and depression, and improve cognitive function from traumatic brain injury, according to the study, published in 2024 in the eminent journal Nature Medicine. Other studies have shown benefits treating addiction and depression. What do critics say? One issue with ibogaine is the ability to produce it, because it is derived from a rare plant and has mostly been used for ceremonial purposes. There is research to help innovate its safe production, but it could be difficult for the drug to be more widely available, as researchers at the University of California, Davis, Institute for Psychedelics and Neurotherapeutics have said. And while it's shown benefits with combat veterans, questions remain on its efficacy among randomized participants. With Texas' research, ibogaine could get closer to FDA approval for its use as a medication.

This New Test Could Diagnose Parkinson's With AI
This New Test Could Diagnose Parkinson's With AI

Newsweek

time15 hours ago

  • Newsweek

This New Test Could Diagnose Parkinson's With AI

Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. A new artificial intelligence (AI) tool analyzing short smile videos achieved high accuracy in screening for Parkinson's disease (PD), according to research published by Tariq Adnan, and colleagues in the New England Journal of Medicine (NEJM) Thursday. The model was trained on the largest known video dataset of facial expressions to date, enrolling 1,452 participants, including 391 living with PD. An 87.9 percent overall accuracy in detecting PD using only smile video analysis, the NEJM AI study reported. Researchers reported that the AI model could accurately distinguish between individuals with and without PD based on the analysis of their smiles, even when applied in diverse population samples from North America and Bangladesh. Why It Matters The Parkinson's Foundation says an estimated 90,000 more people will be diagnosed this year, with the number of those suffering expected to be around 1.2 million by 2030. Diagnosing Parkinson's disease early remains a significant challenge because of limited access to clinical expertise and in-person evaluations. AI-driven remote screening tools promise scalable, cost-effective solutions to bridge these healthcare gaps. The findings align with the growing demand for digital healthcare solutions that remove geographical and economic barriers to early neurological disease diagnosis, which is especially relevant to rural and underserved American communities. What To Know The new screening method invited participants to record themselves mimicking facial expressions—including a smile—using an online platform. Research teams then extracted facial landmarks and measured action units to quantify hypomimia, a common motor symptom in PD where facial muscle movement is diminished. Machine learning models were developed using these features, distinguishing people with PD from those without. The approach relied on a broad recruitment strategy, involving participants from North America via social media, email, wellness centers, and research registries, alongside a high-risk cohort from Bangladesh. Trained solely on smile videos, the model achieved a 10-fold cross-validated accuracy of 87.9 percent, a sensitivity of 76.8 percent, and a specificity of 91.4 percent. Validation in external test sets revealed 80.3 percent accuracy in a U.S. clinic dataset and 85.3 percent accuracy in the Bangladesh cohort. While the negative predictive value remained above 92 percent in all settings, the positive predictive value dropped to 35.7 percent among the Bangladeshi participants, reflecting variations in population characteristics. The study found no significant differences in model performance across sex and ethnic subgroups, except for marginally higher accuracy in female participants in Bangladesh. The authors emphasized the generalizability and fairness of the approach, key considerations in the development of clinical AI tools. The video-processing and machine-learning code supporting the study is available to the public on GitHub. However, the study authors noted that raw video data sharing is restricted to comply with U.S. healthcare privacy law (HIPAA), limiting access to de-identified derivative features only. The research received funding from the National Institute of Neurological Disorders and Stroke at the National Institutes of Health, among other sources. The work was a collaborative effort involving academic and clinical partners such as the InMotion Parkinson's Disease wellness center and the University of Rochester Center for Health and Technology. The research process also benefited from contributions by staff at Google Research and the University of Rochester, particularly in statistical analysis. Stock image of brain MRI taken November 21, 2018. Stock image of brain MRI taken November 21, 2018. Getty What People Are Saying Tariq Adnan, lead author said in the study conclusion: "Smiling videos can effectively differentiate between individuals with and without PD, offering a potentially easy, accessible, and cost-efficient way to screen for PD, especially when access to clinical diagnosis is limited." What Happens Next? Future steps for the research team involve wider validation of the AI screening method in additional, real-world populations and further refinement of the algorithm to maximize early detection accuracy. Regulatory and clinical translation pathways will determine if and when this technology becomes available in the United States healthcare system.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store